Pfizer Shares Hit 52-Week High as Drugmakers Rally
Pfizer shares reached $29.88 Thursday, clearing the previous 52-week peak of $29.21, as drugmakers rose broadly. The FDA approved a Tukysa regimen on Oct. 7.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.